Latest Insider Transactions at Kezar Life Sciences, Inc. (KZR)
This section provides a real-time view of insider transactions for Kezar Life Sciences, Inc. (KZR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kezar Life Sciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kezar Life Sciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2024
|
Mark C. Schiller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,688
-16.85%
|
$0
$0.58 P/Share
|
|
Aug 15
2023
|
Morningside Venture Investments LTD |
SELL
Bona fide gift
|
Direct |
3,500,000
-64.24%
|
-
|
|
Jul 20
2023
|
Christopher J. Kirk CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
48,950
+10.19%
|
$0
$0.9 P/Share
|
|
Feb 06
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
40,000
-0.73%
|
$240,000
$6.88 P/Share
|
|
Feb 03
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
25,000
-0.45%
|
$175,000
$7.15 P/Share
|
|
Feb 02
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
50,000
-0.9%
|
$350,000
$7.19 P/Share
|
|
Feb 01
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
40,000
-0.71%
|
$240,000
$6.95 P/Share
|
|
Jan 31
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
30,000
-0.53%
|
$210,000
$7.08 P/Share
|
|
Jan 30
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
30,000
-0.53%
|
$180,000
$6.91 P/Share
|
|
Jan 25
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
50,000
-0.88%
|
$300,000
$6.85 P/Share
|
|
Jan 24
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
80,000
-1.38%
|
$480,000
$6.98 P/Share
|
|
Jan 23
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
80,000
-1.36%
|
$480,000
$6.81 P/Share
|
|
Jan 17
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
6,114
-0.1%
|
$36,684
$6.79 P/Share
|
|
Jan 13
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
1,971
-0.03%
|
$13,797
$7.15 P/Share
|
|
Jan 12
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$30,000
$6.77 P/Share
|
|
Jan 06
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
3,000
-0.05%
|
$18,000
$6.89 P/Share
|
|
Jan 05
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
12,162
-0.21%
|
$72,972
$6.97 P/Share
|
|
Jan 04
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
30,000
-0.51%
|
$210,000
$7.17 P/Share
|
|
Jan 03
2023
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
500
-0.01%
|
$3,500
$7.1 P/Share
|
|
Dec 29
2022
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
25,000
-0.42%
|
$175,000
$7.1 P/Share
|
|
Nov 10
2022
|
John Franklin Fowler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+6.41%
|
$0
$0.9 P/Share
|
|
Oct 04
2022
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
3,612
-0.06%
|
$28,896
$8.82 P/Share
|
|
Oct 03
2022
|
Morningside Venture Investments LTD |
SELL
Open market or private sale
|
Direct |
28,700
-0.47%
|
$229,600
$8.78 P/Share
|
|
Jun 23
2022
|
Christopher J. Kirk CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,060
+7.98%
|
$0
$0.9 P/Share
|
|
Mar 21
2022
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
20,000
+2.2%
|
$280,000
$14.77 P/Share
|
|
Mar 18
2022
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
60,000
+3.35%
|
$960,000
$16.48 P/Share
|
|
Jan 03
2022
|
Michael Kauffman |
SELL
Open market or private sale
|
Direct |
5,000
-7.28%
|
$80,000
$16.45 P/Share
|
|
Jan 03
2022
|
Michael Kauffman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.79%
|
$25,000
$5.91 P/Share
|
|
Dec 14
2021
|
John Franklin Fowler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+2.06%
|
$0
$0.9 P/Share
|
|
Sep 22
2021
|
Franklin M Berger |
BUY
Exercise of conversion of derivative security
|
Direct |
8,896
+1.09%
|
$44,480
$5.6 P/Share
|
|
Sep 21
2021
|
Franklin M Berger |
BUY
Exercise of conversion of derivative security
|
Direct |
17,792
+1.1%
|
$106,752
$6.77 P/Share
|
|
Dec 31
2020
|
John Franklin Fowler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+4.26%
|
$0
$0.9 P/Share
|
|
May 30
2019
|
Vassiliki Economides SVP, Strategy & External Aff. |
BUY
Open market or private purchase
|
Direct |
750
+6.21%
|
$7,500
$10.19 P/Share
|
|
Jun 25
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+13.71%
|
$3,750,000
$15.0 P/Share
|
|
Jun 25
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,322,909
+46.62%
|
-
|
|
Jun 25
2018
|
Onyx Therapeutics, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,121,384
+50.0%
|
-
|